Latest Financial Health News

Australia and New Zealand Banking Group Limited (ANZ) has announced a quarterly distribution of AUD 1.4438 per security on its capital notes, payable in June 2026, with a 70% franking component and tax considerations for investors.

Gowing Bros Limited has announced a fully franked ordinary dividend of AUD 0.03 per share for the half-year ending January 2026, alongside a Dividend Reinvestment Plan offering shareholders a choice to reinvest without discount.

KMD Brands Limited has announced plans for a capital raise via placement and AREO, coinciding with its upcoming half-year financial results. The company has requested a trading halt as it finalises the terms.

EVT Limited has successfully refinanced its debt facilities, increasing capacity to $750 million with improved interest margins, positioning the group for its strategic pivot towards the hotel sector.

Bubalus Resources has streamlined its project portfolio and cut corporate costs, sharpening its focus on priority gold and critical minerals assets in Victoria and the Northern Territory.

Premier Investments reported a modest 0.38% rise in net profit from continuing operations for the half-year ending January 2026, alongside a 3% increase in revenue and a fully franked interim dividend of 45 cents per share.

First Lithium Limited’s shares have been suspended from trading on the ASX due to a missed reporting deadline, raising questions about the company’s compliance and near-term outlook.

Calix Limited has successfully completed the first milestone of its ARENA grant for the Zesty Green Iron Demonstration Project, unlocking a $2 million payment and marking a key step forward in its industrial decarbonisation efforts.

Reliance Worldwide Corporation has announced an additional A$120 million on-market share buy-back, reinforcing its confidence in the company’s strategy and financial health.

Evolution Mining has confirmed a fully franked dividend of AUD 0.20 per share for the half-year ending December 2025, alongside a Dividend Reinvestment Plan price set at AUD 14.4695 with no discount.

NTAW Holdings has secured an extension of its financial covenant waiver from Commonwealth Bank, easing short-term credit pressures while continuing repayments on its borrowing facility.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.